Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS and the mycoses.

A M Macher1, M L De Vinatea, S M Tuur

  • 1Collaborative Center for the Investigation of AIDS, Armed Forces Institute of Pathology, Washington, DC.

Infectious Disease Clinics of North America
|December 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kaposi's sarcoma in women: A clinicopathologic study.

Journal of cutaneous medicine and surgery·1999
Same author

Lymphoid markers, activation markers, and adhesion molecules in cutaneous biopsy specimens from HIV+ patients with disease progression. The Military Medical Consortium for the Advancement of Retroviral Research.

Journal of cutaneous medicine and surgery·1998
Same author

Histopathologic features seen in cutaneous photoeruptions in HIV-positive patients. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).

International journal of dermatology·1997
Same author

Issues regarding antiretroviral treatment for patients with HIV-1 infection.

JAMA·1997
Same author

The diagnostic laboratory as clinical consultant: public health implications.

American journal of clinical pathology·1997
Same author

Inmate access to postrelease medical care: public health implications.

Archives of family medicine·1997
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Patients with acquired immunodeficiency syndrome (AIDS) are highly susceptible to opportunistic infections, particularly fungal infections. These mycotic complications are often severe and difficult to treat, posing significant challenges in patient management.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Mycology

Background:

  • Patients with acquired immunodeficiency syndrome (AIDS) exhibit profound immunoincompetence.
  • This immune deficiency renders them vulnerable to a wide range of opportunistic pathogens, including fungi.
  • Opportunistic infections in AIDS patients are frequently severe, persistent, and may relapse despite treatment.

Purpose of the Study:

  • To describe the spectrum and characteristics of mycotic complications in patients with acquired immunodeficiency syndrome (AIDS).

Main Methods:

  • Review of clinical data and literature pertaining to fungal infections in AIDS patients.
  • Analysis of the types of fungal pathogens involved and their clinical manifestations.
  • Evaluation of treatment challenges and outcomes for mycotic infections in this population.

Related Experiment Videos

Main Results:

  • Fungal infections are a significant cause of morbidity and mortality in patients with AIDS.
  • Common mycotic complications include candidiasis, cryptococcosis, and histoplasmosis.
  • These infections often present with severe, relapsing, and sometimes untreatable courses.

Conclusions:

  • Mycotic complications represent a critical aspect of opportunistic infections in acquired immunodeficiency syndrome (AIDS).
  • Effective management strategies are essential to address the severity and persistence of these fungal infections.
  • Further research is needed to develop more effective and potentially curative therapies for untreatable mycotic infections in AIDS patients.